Mokhtar Helen, Pedrera Miriam, Frossard Jean-Pierre, Biffar Lucia, Hammer Sabine E, Kvisgaard Lise K, Larsen Lars E, Stewart Graham R, Somavarapu Satyanarayana, Steinbach Falko, Graham Simon P
Virology Department, Animal and Plant Health Agency, Addlestone, UK; Department of Microbial and Cellular Sciences, University of Surrey, Guildford, UK.
Virology Department, Animal and Plant Health Agency , Addlestone , UK.
Front Immunol. 2016 Feb 16;7:40. doi: 10.3389/fimmu.2016.00040. eCollection 2016.
The porcine reproductive and respiratory syndrome virus (PRRSV) is the cause of one of the most economically important diseases affecting swine worldwide. Efforts to develop a next-generation vaccine have largely focused on envelope glycoproteins to target virus-neutralizing antibody responses. However, these approaches have failed to demonstrate the necessary efficacy to progress toward market. T cells are crucial to the control of many viruses through cytolysis and cytokine secretion. Since control of PRRSV infection is not dependent on the development of neutralizing antibodies, it has been proposed that T cell-mediated immunity plays a key role. Therefore, we hypothesized that conserved T cell antigens represent prime candidates for the development a novel PRRS vaccine. Antigens were identified by screening a proteome-wide synthetic peptide library with T cells from cohorts of pigs rendered immune by experimental infections with a closely related (subtype 1) or divergent (subtype 3) PRRSV-1 strain. Dominant T cell IFN-γ responses were directed against the non-structural protein 5 (NSP5), and to a lesser extent, the matrix (M) protein. The majority of NSP5-specific CD8 T cells and M-specific CD4 T cells expressed a putative effector memory phenotype and were polyfunctional as assessed by coexpression of TNF-α and mobilization of the cytotoxic degranulation marker CD107a. Both antigens were generally well conserved among strains of both PRRSV genotypes. Thus, M and NSP5 represent attractive vaccine candidate T cell antigens, which should be evaluated further in the context of PRRSV vaccine development.
猪繁殖与呼吸综合征病毒(PRRSV)是全球影响养猪业的最具经济重要性的疾病之一的病因。开发下一代疫苗的努力主要集中在包膜糖蛋白上,以靶向病毒中和抗体反应。然而,这些方法未能证明在推向市场方面所需的疗效。T细胞通过细胞溶解和细胞因子分泌对许多病毒的控制至关重要。由于PRRSV感染的控制不依赖于中和抗体的产生,因此有人提出T细胞介导的免疫起着关键作用。因此,我们假设保守的T细胞抗原是开发新型PRRS疫苗的主要候选物。通过用来自经密切相关(1型亚型)或不同(3型亚型)PRRSV-1毒株实验感染而免疫的猪群的T细胞筛选全蛋白质组合成肽文库来鉴定抗原。主要的T细胞IFN-γ反应针对非结构蛋白5(NSP5),在较小程度上针对基质(M)蛋白。大多数NSP5特异性CD8 T细胞和M特异性CD4 T细胞表达推定的效应记忆表型,并且通过TNF-α的共表达和细胞毒性脱颗粒标记物CD107a的动员评估为多功能。两种抗原在两种PRRSV基因型的毒株中通常都高度保守。因此,M和NSP5代表有吸引力的疫苗候选T细胞抗原,应在PRRSV疫苗开发的背景下进一步评估。